Cambridge in Africa
Professors David Dunne, James Wood, and Dr Pauline Essah explain why, in the quest for understanding infectious diseases, Africa may hold the answers.
A novel MRSA in cows...where do we go from here?
This month, we interviewed Dr Mark Holmes from the Department of Veterinary Medicine. Mark was recently interviewed on the Today programme about his involvement in a recent study of divergent strains of MRSA, published in the Lancet Infectious Diseases.
New clue in the battle against Australian Hendra virus
A new study on African bats provides a vital clue for unravelling the mysteries in Australia’s battle with the deadly Hendra virus.
Calling Enterprising Women in Science Engineering and Technology!
EnterpriseWISE A programme for PhD and women researchers in Science, Engineering and Technology
First Annual Cambridge Infectious Diseases Invited Lecture Announced
Dr Paul Newton (Wellcome Trust Overseas Programme, Laos) and Aline Plancon (Interpol) have been invited to Cambridge to discuss the challenges of fake antimicrobial drugs.
Malaria's achilles heel revealed?
Researchers at the Wellcome Trust Sanger Institute, have revealed a key discovery in understanding how the most deadly species of malaria parasite, Plasmodium falciparum, invades human red blood cells.
Cartographers of the infectious world
Cambridge scientists, and their map-making skills, are contributing to an annual worldwide public health endeavour – the race to select a vaccine against seasonal flu.
Addenbrooke's Abroad announces its partnership with the Humanitarian Centre
Addenbrooke's Abroad is delighted to announce its partnership with the Humanitarian Centre for its Cambridge Global Health Year
Scientists find mechanism that leads to drug resistance in bacteria causing melioidosis
Researchers have identified a novel mechanism whereby the organism Burkholderia pseudomallei that causes melioidosis, a neglected tropical infectious disease, develops resistance to the standard antibiotic treatment.
THRiVE programme update
The THRiVE Programme in Cambridge aims to provide research training and mentorship to PhD and postdoctoral researchers in Africa. Two African researchers will be visiting Cambridge for the next three months, and each will be give a talk about their individual research projects.
Developing Leaders: Widening the Pool of Research Experience
The Engineering and Physical Sciences Research Council has allocated the University of Cambridge a small fund to enable individuals who are currently in non-research roles to work as research interns for short periods in a typical research environment. The objective is to encourage them to consider research as a career, or to re-enter the research arena after a break, and thus broaden the diversity of backgrounds and experience represented in the EPSRC sponsored pool of researchers.
STEM projects needed
Do you have small projects that could be performed by an A-Level student over the summer? The local STEM (Science Technology, Engineering and Medicine) team are seeking suitable projects.
Bats and Bugs at the Royal Society
Scientists from Cambridge will be taking part in the "Bats and Bugs" exhibit at the Royal Society 'Science Live' festival. The exhibit will showcase the multi-disciplinary research programme led by Prof. James Wood (Cambridge) and Prof. Andrew Cunningham (Zoological Society of London) on the ecology and epidemiology of bat-borne pathogens.
More than 100 research reagents available for licensing through Cambridge Enterprise
Cambridge Enterprise has passed an important milestone in its efforts to bring the benefit of research reagents generated at the University of Cambridge to the worldwide research community, with more than 100 reagents now available for licensing.
28 Minutes Later - The Maths of Zombies
So, to survive a zombie attack you need to run. In the long term we need a fortified society, but if the barricades fall we need to reduce the speed of infection, slow them down, and be more deadly than they are.
Are your reagents valuable?
Commercial suppliers are keen to sell research reagents such as antibodies, cell lines, proteins and DNA constructs developed in University Labs and share the proceeds. From the academic researcher's perspective, using the commercial route to distribute reagents can ensure that they are readily available to other scientists whilst saving time and resources, and generating revenue.